Keyphrases
Pharmacodynamics
100%
Phase I Clinical Trial
100%
Epothilone B
100%
Bundle Generation
100%
Peripheral Blood Mononuclear Cells
57%
Multidrug Resistance Protein 1 (MDR1)
57%
Microtubule Bundles
57%
Tubulin
42%
Area under the Curve
42%
Polymorphism
28%
Cell Death
28%
Partial Response
14%
Tumor Cells
14%
Multidrug Resistance
14%
Dose Level
14%
Phase I Trial
14%
Pharmacokinetics
14%
In Vivo Pharmacokinetics
14%
Associated Proteins
14%
Poly(ADP-ribose) Polymerase
14%
Breast Tumor Cells
14%
Dose-response
14%
Tumor Biopsy
14%
Drug Exposure
14%
Tumor Samples
14%
Drug Infusion
14%
Patient Tumor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Clinical Study
100%
Pharmacodynamics
100%
Epothilone B
100%
Tubulin
75%
Multidrug Resistance Protein 1
50%
Multidrug Resistance Associated Protein 1
50%
Pharmacokinetics
25%
Phase I Trials
25%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
25%
Multiple Drug Resistance
25%
Breast Tumor
25%
Immunology and Microbiology
Microtubule
100%
Peripheral Blood Mononuclear Cell
100%
Pharmacodynamics
100%
Tumor Cell
50%
Cell Death
50%
Multidrug Resistance Protein 1
50%
Blood Plasma
25%
Multidrug Resistance
25%
Carboxy Terminal Sequence
25%
Drug Exposure
25%
Pharmacokinetics
25%
Dose Response
25%
Drug Blood Level
25%
Biochemistry, Genetics and Molecular Biology